ESR1 and breast cancer: In vivo data showed that CCNA2 expression was down-regulated in MCF-7 tumor xenografts treatment with tamoxifen compared with control (Fig. 1D, P = 0.01), which indicates that tamoxifen could decrease CCNA2 expression in ER+ breast cancer cells.